AzTrials
AzTrials

Low Back PainNCT06712992

Electromyographic Response to TsDcs in CNSLBP

A study testing Trans-spinal Direct Current Stimulation and Conventional Exercises in people with Low Back Pain, run by German International University at 2 sites in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this randomized, double-blinded, sham-controlled study is to investigate the efficacy of trans-spinal direct current stimulation on pain level, quality of life, and electromyographic nociceptive flexion reflex in patients with non-specific chronic low back pain. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Low Back Pain
What is being tested?
Trans-spinal Direct Current Stimulation and Conventional Exercises
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
2 sitesEgypt
Study dates
16 May 2024to 10 Apr 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Individuals of both sexes.
  • Age 18-60 years old.
  • Chronic non-specific low back pain according to the most recent guidelines for the diagnosis and management of NSLPB come from the American College of Physicians and was published in 2017. According to these guidelines, the diagnosis of chronic NSLBP should be made based on the following criteria:
  • Chronic low back pain, defined as pain lasting for more than 12 weeks.
  • No specific identifiable cause of pain(e.g. infection, malignancy, fracture, inflammatory disorder).
  • No radicular symptoms(e.g. pain radiating down the leg).
  • No significant neurological deficits or findings on physical examination(e.g. loss of reflexes or muscle strength).

Who cannot join

  • Previous fractures and/or surgery in the vertebral spine.
  • Neuropathic pain extending along the lower limb due to nerve root compression.
  • History of spine trauma or fracture.
  • Implanted pacemakers.
  • Pregnancy.
  • Malignancy.
Show all 10Show fewer
  • Systemic musculoskeletal diseases.
  • Epilepsy.
  • History of psychiatric disorders.
  • Obesity

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • Outpatient clinic of faculty of physical therapy, Ahram Canadian University

    Sixth of October, Giza Governorate, 12611

  • Outpatient clinical of faculty of physical therapy, Ahram Canadian University

    Sixth of October, Giza Governorate, 12611

Other trials in Egypt

About this study

Official title: Effect of Trans-Spinal Direct Current Stimulation in the Management of Non-Specific Chronic Low Back Pain: A Randomized Controlled Trial

The purpose of this randomized, double-blinded, sham-controlled study is to investigate the efficacy of trans-spinal direct current stimulation on pain level, quality of life, and electromyographic nociceptive flexion reflex in patients with non-specific chronic low back pain.

Conditions
Low Back Pain
Being tested
Trans-spinal Direct Current Stimulation, Conventional Exercises, SHAM Trans-spinal Direct current stimulation
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trans-spinal Direct Current StimulationDevice

    Physiomed- IONOSON-Expert, Germany will be used to deliver SHAM direct current, The Physiomed- IONOSON-Expert, Germany is Two-channel electrotherapy including 21 currents, including direct current. The tsDCS electrodes will be rectangular pieces of saline-soaked synthetic sponge (7 × 8 cm, 56 cm2), to minimize chemical reactions at the electrode-skin interface. The anode will be placed over the spinous process of the eighth thoracic vertebra (T8) and the cathode will be placed on the second lumbar vertebra (L2) according to a modeling study which demonstrated that this configuration had a relevant impact on the distribution of the induced electric field (EF) in the lumbosacral spinal cord for the efficacy of tsDCS.

  • Conventional ExercisesOther

    1. Isometric exercises of spine
    • Hollowing in abdominals.
    • Isometric for back extensors.
    1. Bridging exercises.
    2. Graded active flexion exercises of spine
    3. Graded active extension exercises of spine
  • SHAM Trans-spinal Direct current stimulationDrug

    For a sham tsDCS, the current will be ramped up for 30 seconds turned on for 5 s and then turned off in a ramp shaped fashion, thus inducing skin sensations indistinguishable from anodal tsDCS. This method was shown to achieve a good level of blinding among sessions.

    These parameters for sham stimulation were chosen based on previous reports that the perceived sensations on the skin, such as tingling, fade usually out in the first 30 s of TsDcs .

Study groups in NCT06712992
Study groupRoleWhat they receive
Trans-spinal direct current stimulation groupExperimentalPatients in this group will receive Conventional Exercises in addition to tsDCS. We will apply a current density of 0.035 mA/cm2 and will deliver a total charge density of 42.8 mC/cm2, below the threshold values reported for tissue damage. For tsDcs, At the onset of tsDCS, the current will be increased for 30 s, and at the offset, it will be decreased for 30 s in a ramp-like manner. Participants will receive three sessions of treatment per week for four weeks, with a total of twelve sessions.
Receives: Device: Trans-spinal Direct Current Stimulation; Other: Conventional Exercises
Sham Trans-spinal direct current stimulation groupSham comparatorPatients in this group will receive Conventional Exercises in addition to SHAM tsDCS. For a sham tsDCS, the current will be ramped up for 30 seconds turned on for 5 s and then turned off in a ramp shaped fashion, thus inducing skin sensations indistinguishable from anodal tsDCS. This method was shown to achieve a good level of blinding among sessions. Participants will receive three sessions of treatment per week for four weeks, with a total of twelve sessions.
Receives: Other: Conventional Exercises; Drug: SHAM Trans-spinal Direct current stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in NPRS from baseline to four weeks

    An 11-point Numerical Pain Rating Scale (NPRS; 0= no pain, 10= maximum pain) will be used to assess the patients' pre and post treatment levels of back pain. The NPRS can be administered verbally (therefore also by telephone) or graphically for self-completion. Scores range from 0-10 points, with higher scores indicating greater pain intensity

    Measured: Baseline and 4 weeks

Secondary outcomes (2)
  1. Changes in Nociceptive Flexion Reflex (NFR) Threshold and area from baseline to 4 weeks

    The NFR threshold will be assessed as an objective measure of spinal nociceptive processing in adults with chronic non-specific low back pain (CNSLBP). The NFR threshold will be defined as the lowest stimulus intensity that elicits an NFR response.The NFR threshold and NFR area will be assessed before and after 4 weeks of trans-spinal direct current stimulation (tsDCS) plus exercise or sham stimulation plus exercise.

    Measured: Baseline and 4 weeks

  2. Changes in PROMIS Global Health - 10 Survey from baseline to 4 weeks

    The Patient-Reported Outcomes Measurement Information System (PROMIS) is a comprehensive instrument designed to assess health-related quality of life across various domains. PROMIS GH-10, specifically, is tailored to measure global physical and mental health. It encompasses a range of items that evaluate general health perceptions, physical function, pain, fatigue, emotional distress, and social health. PROMIS GH-10 has been demonstrated to be reliable and valid for use in the general population and various specific conditions, such as low back pain.

    Measured: Baseline and 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2024
  2. Study start16 May 2024
  3. Primary completion1 Apr 2025 (estimated)
  4. Study completion10 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06712992
Sponsor's protocol ID
P.T/REC/2024.10021
Status last verified
Mar 2025
First submitted
26 Nov 2024
Last updated
12 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Trans-spinal Direct Current Stimulation and Conventional Exercises in people with Low Back Pain, run by German International University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 12 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in NPRS from baseline to four weeks (time frame: Baseline and 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in